NCT01594190

Brief Summary

Stroke is the leading cause of adult disability in Europe and United States and the second leading cause of death worldwide and affects more than 10,000 Danes each year. Studies in a late and stationary phase after stroke have shown that physical rehabilitation is of great importance for survival and physical ability of these patients, however many studies show that patients lie or sit next to their bed under hospitalization for more than 88.5 % of the daily hours. Physical activity in stroke patients has never previously been measured immediately after debut of symptoms; furthermore there is no knowledge about the optimal dose of physical rehabilitation for these patients. Accelerometers, small measuring devices, are a relatively new way to measure physical activity precisely, and hence it is possible to obtain an objective measure of how active stroke patients are in the first week after admission. The accelerometers measure a variable voltage, depending on the range and intensity of movement. They can measure movement dependent of the placement of the accelerometer, for instance over the hip, arm or leg. Studies confirm their reliability, even in patients with abnormal gait, such as stroke patients. Another approach of studying the effects of physical activity and rehabilitation is through the examination of biomarkers. Studies have shown that biomarkers released during physical activity can inhibit biomarkers released after tissue injury in the brain, as seen after stroke. These brain biomarkers cause further damage and studies show that the higher the levels, the higher the damage. It is therefore obvious to examine whether physical activity rehabilitation can down regulate this destructive process in patients with stroke. Clarification of the optimal dose of physical activity in stroke patients immediately after debut of symptoms and examination of both the biochemical aspects of physical rehabilitation as well as the optimal dose of physical rehabilitation is of great importance for many patients, their relatives as well as of a great socioeconomic importance. The purpose of the project is to investigate which dose (15 vs. 2 x 30 minutes) of physical activity on a weight-bearing treadmill in the first 5 days after admission after an ischemic stroke, gives patients the best improvement in neurological dysfunction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2011

Completed
6 months until next milestone

First Posted

Study publicly available on registry

May 8, 2012

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

May 9, 2012

Status Verified

May 1, 2012

Enrollment Period

1.8 years

First QC Date

November 2, 2011

Last Update Submit

May 8, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in disability from baseline

    Scandinavian Stroke Scale (SSS)

    up to 5 days

Secondary Outcomes (4)

  • change in inflammation level from baseline

    up to 5 days

  • change in disability from baseline

    up to 5 days

  • changes and level of activity during up to 5 days of hospitalization

    up to 5 days

  • number of complications per patient

    up to 30 days

Study Arms (2)

Low Dose Training

ACTIVE COMPARATOR

15 minutes/day on a weight-bearing treadmill

Behavioral: physical activity 15 minutes/day

High Dose Training

ACTIVE COMPARATOR

2x 30 minutes/day on a weight-bearing treadmill

Behavioral: physical activity, 2 x 30 minutes/day

Interventions

weight-bearing treadmill, pulsereserve increase of 50 %

Low Dose Training

weight-bearing treadmill, pulsereserve increase of 50 %

High Dose Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients admitted with acute ischemic stroke
  • age \> 18 years
  • first stroke or only minor invalidity from previous strokes (mRS 0-2)
  • truncal stability
  • SSS \< 58

You may not qualify if:

  • symptoms attributable to other diseases than ischemic stroke
  • debut of symptoms \> 48 h prior to admission
  • consent not given \< 24 h of admission
  • pregnancy or lactation
  • isolation
  • blood sampling generally not possible
  • allergy due to accelerometer wear
  • ulcers or other skin diseases in the area of accelerometer placement
  • unstable cardiologic condition (AMI etc.)
  • acute high and sustained resting systolic blood pressure where treatment is necessary
  • acute heart rhythm disorder where treatment is necessary
  • unable to cooperate
  • significant orthopedic conditions (fractures etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hillerød Hospital

Hillerød, 3400, Denmark

Location

MeSH Terms

Conditions

Ischemic StrokeMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Anna Maria Strømmen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical assistant

Study Record Dates

First Submitted

November 2, 2011

First Posted

May 8, 2012

Study Start

September 1, 2012

Primary Completion

July 1, 2014

Study Completion

September 1, 2014

Last Updated

May 9, 2012

Record last verified: 2012-05

Locations